New research suggests that individuals who come off popular GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight much more quickly than those who end traditional lifestyle regimens.
Findings released in a leading health publication shows that while overweight people often shed substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Users purchasing these drugs should be informed of the danger of rapid weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery suggests a return to original mass within about a year and a half.
Comparing Treatments
The study, which reviewed 37 of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods.
Researchers point out that individuals who lose weight through lifestyle changes alone generally have a less rapid weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Quick Regain
Experts believe the mode of action of the jabs explains the heightened weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means appetite is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals contend that, given the significant potential of relapse, the therapy should be considered life-long.
This view is reinforced by pharmaceutical companies, who say that the results "underscore the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
Users who have come off the medication describe a powerful return of appetite.
"It felt as if a trigger that goes on and you're instantly extremely hungry," said one woman.
This difficulty is compounded if individuals have not established lasting lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Use is more common among females than males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Finally, clinicians caution that while these medications are powerful agents for weight loss, they are not a permanent fix and long-term success hinges on ongoing behavioural support.